Boehringer Ingelheim Human Pharma News and Activities
Presence
Headquarters: Germany
Boehringer Ingelheim has 16 subsidiaries including Boehringer Ingelheim Animal Health USA, Boehringer Ingelheim Asia and Boehringer Ingelheim Belgium.
Executives
View the org chart displaying its 3 main executives
Most searched biographies at Boehringer Ingelheim Human Pharma
- Christoph Ruland, General Manager
- Michael Horn, Head of Global Commercial Business
- Thorsten Poehl, Senior Vice President, Emerging Markets
Popular executive movements at Boehringer Ingelheim Human Pharma
- Francesco Di Marco, Head of Regions, has left the company (posted on October 13 2025).
Popular executive movements at Boehringer Ingelheim
- Mohammed Tawil, who was Chairman and Chief Executive Officer, Hong Kong and Taiwan, is promoted to Senior Vice President, Head of Emerging Markets (posted on April 20 2026).
- Harsha Deshmukh will join the company as Director, Information Technology and Global Business Services on Feb. 1, 2026 (posted on December 1 2025).
Create your alert
to follow the executive moves at Boehringer Ingelheim Human Pharma.
Pharmaceuticals
Boehringer Ingelheim has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Corden Pharma has announced the acquisition of AmbioPharm (posted on June 5 2026).
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Boehringer Ingelheim Human Pharma
Social media about Boehringer Ingelheim Human Pharma
- Boehringer Ingelheim Human Pharma on Wikipedia, Google News & Yahoo Finance
- Boehringer Ingelheim Human Pharma on LinkedIn, X (Twitter) & YouTube
